Placenta
Volume 31, Issue 10 , Pages 893-901 , October 2010

Changes in the Metabolic Footprint of Placental Explant-Conditioned Medium Cultured in Different Oxygen Tensions from Placentas of Small for Gestational Age and Normal Pregnancies

  • R.P. Horgan

      Affiliations

    • The Anu Research Centre, Department of Obstetrics and Gynaecology, University College Cork, Cork University Maternity Hospital, Cork, Ireland
    • Corresponding Author InformationCorresponding author. Tel.: +353 21 4205023; fax: +353 21 4205025.
    • ,
  • D.I. Broadhurst

      Affiliations

    • The Anu Research Centre, Department of Obstetrics and Gynaecology, University College Cork, Cork University Maternity Hospital, Cork, Ireland
    • ,
  • W.B. Dunn

      Affiliations

    • The Manchester Centre for Integrative Systems Biology, The University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK
    • School of Chemistry, Manchester Interdisciplinary Biocentre, The University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK
    • Centre for Advanced Discovery and Experimental Therapeutics, Manchester Biomedical Research Centre, University of Manchester, Manchester, UK
    • ,
  • M. Brown

      Affiliations

    • The Manchester Biomedical Research Centre, Manchester Royal Infirmary and University of Manchester, UK
    • ,
  • A.E.P. Heazell

      Affiliations

    • The Maternal and Fetal Health Research Centre, The University of Manchester, St Mary’s Hospital, Whitworth Park, Manchester M13 0JH, UK
    • ,
  • D.B. Kell

      Affiliations

    • The Manchester Centre for Integrative Systems Biology, The University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK
    • School of Chemistry, Manchester Interdisciplinary Biocentre, The University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK
    • ,
  • P.N. Baker

      Affiliations

    • Faculty of Medicine & Dentistry, University of Alberta, 2J2.01 WMC, 8440 – 112 Street, Edmonton, AB T6G 2R7 Canada
    • ,
  • L.C. Kenny

      Affiliations

    • The Anu Research Centre, Department of Obstetrics and Gynaecology, University College Cork, Cork University Maternity Hospital, Cork, Ireland

,Accepted 8 July 2010.

References 

  1. McIntire DD, Bloom SL, Casey BM, Leveno KJ. Birth weight in relation to morbidity and mortality among newborn infants. N Eng J Med. 1999;340(16):1234–1238
  2. Clausson B, Gardosi J, Francis A, Cnattingius S. Perinatal outcome in SGA births defined by customised versus population-based birthweight standards. Br J Obstet Gynaecol. 2001;108(8):830–834
  3. Law CM, Shiell AW, Newsome CA, Syddall HE, Shinebourne EA, Fayers PM, et al. Fetal, infant, and childhood growth and adult blood pressure – a longitudinal study from birth to 22 years of age. Circulation. 2002;105(9):1088–1092
  4. Barker DJP. The fetal origins of type 2 diabetes mellitus. Ann Intern Med. 1999;130(4):322–324
  5. Goldenberg RL, Cliver SP. Small for gestational age and intrauterine growth restriction: definitions and standards. Clin Obstet Gynecol. 1997 Dec;40(4):704–714
  6. Gardosi J. New definition of small for gestational age based on fetal growth potential. Horm Res. 2006;65(Suppl. 3):15–18
  7. McCowan LME, Harding JE, Stewart AW. Customised birthweight centiles predict SGA pregnancies with perinatal morbidity. BJOG. 2005;112(8):1026–1033
  8. Trudinger BJ, Giles WB. Elaboration of stem villous vessels in growth restricted pregnancies with abnormal umbilical artery Doppler waveforms. Br J Obstet Gynaecol. 1996;103(5):487–488
  9. Jackson MR, Walsh AJ, Morrow RJ, Mullen JBM, Lye SJ, Ritchie JW. Reduced placental villous tree elaboration in small-for-gestational-age pregnancies – relationship with umbilical artery Doppler wave-forms. Am J Obstet Gynecol. 1995;172(2):518–525
  10. Weedon MN, Frayling TM, Shields B, Knight B, Turner T, Metcalf BS, et al. Genetic regulation of birth weight and fasting glucose by a common polymorphism in the islet cell promoter of the glucokinase gene. Diabetes. 2005;54(2):576–581
  11. Gagnon R. Placental insufficiency and its consequences. Eur J Obstet Gynecol Reprod Biol. 2003;110:S99–S107
  12. Smith SC, Baker PN, Symonds EM. Increased placental apoptosis in intrauterine growth restriction. Am J Obstet Gynecol. 1997;177(6):1395–1401
  13. Chen CP, Bajoria R, Aplin JD. Decreased vascularization and cell proliferation in placentas of intrauterine growth-restricted fetuses with abnormal umbilical artery flow velocity waveforms. Am J Obstet Gynecol. 2002;187(3):764–769
  14. Genbacev O, Zhou Y, Ludlow JW, Fisher SJ. Regulation of human placental development by oxygen tension. Science. 1997 Sep 12;277(5332):1669–1672
  15. Crocker IP, Tansinda DM, Jones CJ, Baker PN. The influence of oxygen and tumor necrosis factor-alpha on the cellular kinetics of term placental villous explants in culture. J Histochem Cytochem. 2004 Jun;52(6):749–757
  16. Kingdom JC, Kaufmann P. Oxygen and placental villous development: origins of fetal hypoxia. Placenta. 1997 Nov;18(8):613–621[discussion 23–6]
  17. Khalid ME, Ali ME, Ali KZ. Full-term birth weight and placental morphology at high and low altitude. Int J Gynaecol Obstet. 1997 Jun;57(3):259–265
  18. Heazell AE, Lacey HA, Jones CJ, Huppertz B, Baker PN, Crocker IP. Effects of oxygen on cell turnover and expression of regulators of apoptosis in human placental trophoblast. Placenta. 2008 Feb;29(2):175–186
  19. Heazell AE, Moll SJ, Jones CJ, Baker PN, Crocker IP. Formation of syncytial knots is increased by hyperoxia, hypoxia and reactive oxygen species. Placenta. 2007 Apr;28(Suppl. A):S33–S40
  20. Huppertz B, Kingdom J, Caniggia I, Desoye G, Black S, Korr H, et al. Hypoxia favours necrotic versus apoptotic shedding of placental syncytiotrophoblast into the maternal circulation. Placenta. 2003 Feb–Mar;24(2–3):181–190
  21. Kilani RT, Mackova M, Davidge ST, Guilbert LJ. Effect of oxygen levels in villous trophoblast apoptosis. Placenta. 2003 Sep–Oct;24(8–9):826–834
  22. Miller RK, Genbacev O, Turner MA, Aplin JD, Caniggia I, Huppertz B. Human placental explants in culture: approaches and assessments. Placenta. 2005;26(6):439–448
  23. Heazell AEP, Brown M, Dunn WB, Worton SA, Crocker IP, Baker PN, et al. Analysis of the metabolic footprint and tissue metabolome of placental villous explants cultured at different oxygen tensions reveals novel redox biomarkers. Placenta. 2008;29(8):691–698
  24. Kudo Y, Boyd CA, Sargent IL, Redman CW. Hypoxia alters expression and function of syncytin and its receptor during trophoblast cell fusion of human placental BeWo cells: implications for impaired trophoblast syncytialisation in pre-eclampsia. Biochim Biophys Acta. 2003 May 20;1638(1):63–71
  25. Allen J, Davey HM, Broadhurst D, Heald JK, Rowland JJ, Oliver SG, et al. High-throughput classification of yeast mutants for functional genomics using metabolic footprinting. Nat Biotechnol. 2003;21(6):692–696
  26. O’Hagan S, Dunn WB, Brown M, Knowles JD, Kell DB. Closed-loop, multiobjective optimization of analytical instrumentation: gas chromatography/time-of-flight mass spectrometry of the metabolomes of human serum and of yeast fermentations. Anal Chem. 2005 Jan 1;77(1):290–303
  27. Kell DB, Brown M, Davey HM, Dunn WB, Spasic I, Oliver SG. Metabolic footprinting and systems biology: the medium is the message. Nat Rev Microbiol. 2005;3(7):557–565
  28. Goodacre R, Vaidyanathan S, Dunn WB, Harrigan GG, Kell DB. Metabolomics by numbers: acquiring and understanding global metabolite data. Trends Biotechnol. 2004 May;22(5):245–252
  29. Nicholson JK, Wilson ID. Opinion: understanding ‘global’ systems biology: metabonomics and the continuum of metabolism. Nat Rev Drug Discov. 2003 Aug;2(8):668–676
  30. Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009 Feb 12;457(7231):910–914
  31. Oresic M, Simell S, Sysi-Aho M, Nanto-Salonen K, Seppanen-Laakso T, Parikka V, et al. Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes. J Exp Med. 2008 Dec 22;205(13):2975–2984
  32. van Patot MCT, Murray AJ, Beckey V, Cindrova-Davies T, Johns J, Zwerdlinger L, et al. Human placental metabolic adaptation to chronic hypoxia, high altitude: hypoxic preconditioning. American Journal of Physiology-Regulatory Integrative and Comparative Physiology. 2010;298(1):R166–R172
  33. Dunn WB, Brown M, Worton SA, Crocker IP, Broadhurst D, Horgan R, et al. Changes in the metabolic footprint of placental explant-conditioned culture medium identifies metabolic disturbances related to hypoxia and pre-eclampsia. Placenta. 2009 Nov;30(11):974–980
  34. Gardosi J, Chang A, Kalyan B, Sahota D, Symonds EM. Customized antenatal growth charts. Lancet. 1992;339(8788):283–287
  35. Horgan R, Brown M, Dunn W, Heazell A, Kell D, Kenny L, et al. The difference in the metabolic footprint of placental villous explants cultured in different oxygen tensions. BJOG. 2009;116(10):1409–1410
  36. Krzanowski W. Principles of multivariate analysis: a user’s perspective. Oxford: Oxford Univeristy Press; 1988;
  37. Efron B, Tibshirani R. Improvements on cross-validation: the .632+ bootstrap method. J Am Stat Assoc. 1997;92(438):548–560
  38. Storey JD. A direct approach to false discovery rates. J R Stat Soc Ser B Stat Methodol. 2002;64:479–498
  39. Brown M, Dunn WB, Dobson P, Patel Y, Winder CL, Francis-McIntyre S, et al. Mass spectrometry tools and metabolite-specific databases for molecular identification in metabolomics. Analyst. 2009 Jul;134(7):1322–1332
  40. Bayon Y, Croset M, Chirouze V, Tayot JL, Lagarde M. Phospholipid molecular species from human placenta lipids. Lipids. 1993 Jul;28(7):631–636
  41. Fruhwirth GO, Loidl A, Hermetter A. Oxidized phospholipids: from molecular properties to disease. Biochim Biophys Acta. 2007 Jul;1772(7):718–736
  42. Choy PC, Chan M, Hatch G, Man RY. Phosphatidylcholine metabolism in ischemic and hypoxic hearts. Mol Cell Biochem. 1992 Oct 21;116(1–2):53–58
  43. Tincani A, Cavazzana I, Ziglioli T, Lojacono A, De Angelis V, Meroni P. Complement activation and pregnancy failure. Clin Rev Allergy Immunol. 2009 Nov 11;
  44. Hernandez-Rodriguez J, Meneses L, Herrera R, Manjarrez G. Another abnormal trait in the serotonin metabolism path in intrauterine growth-restricted infants. Neonatology. 2009;95(2):125–131
  45. Hernandez J, Manjarrez GG, Chagoya G. Newborn humans and rats malnourished in utero: free plasma l-tryptophan, neutral amino acids and brain serotonin synthesis. Brain Res. 1989 May 29;488(1–2):1–13
  46. Huang WQ, Zhang CL, Di XY, Zhang RQ. Studies on the localization of 5-hydroxytryptamine and its receptors in human placenta. Placenta. 1998;19(8):655–661
  47. Nicholls T, Nitsos I, Smythe G, Walker DW. Kynurenine production and catabolism in fetal sheep with embolized or nonembolized placentas. Am J Obstet Gynecol. 2001 Oct;185(4):988–995
  48. Kamimura S, Eguchi K, Yonezawa M, Sekiba K. Localization and developmental-change of indoleamine 2,3-dioxygenase activity in the human placenta. Acta Med Okayama. 1991;45(3):135–139
  49. Aubard Y, Darodes N, Cantaloube M. Hyperhomocysteinemia and pregnancy – review of our present understanding and therapeutic implications. Eur J Obstet Gynecol Reprod Biol. 2000 Dec;93(2):157–165
  50. Domagala TB, Undas A, Libura M, Szczeklik A. Pathogenesis of vascular disease in hyperhomocysteinaemia. J Cardiovasc Risk. 1998 Aug;5(4):239–247
  51. Loscalzo J. The oxidant stress of hyperhomocyst(e)inemia. J Clin Invest. 1996 Jul 1;98(1):5–7
  52. Paolini CL, Marconi AM, Ronzoni S, Di Noio M, Fennessey PV, Pardi G, et al. Placental transport of leucine, phenylalanine, glycine, and proline in intrauterine growth-restricted pregnancies. J Clin Endocrinol Metab. 2001 Nov;86(11):5427–5432
  53. Bajoria R, Sooranna SR, Ward S, D’Souza S, Hancock M. Placental transport rather than maternal concentration of amino acids regulates fetal growth in monochorionic twins: implications for fetal origin hypothesis. Am J Obstet Gynecol. 2001 Nov;185(5):1239–1246
  54. Morris NH, Burston D, Ramsay B, Sooranna SR. Free amino acid concentrations in normal and abnormal third trimester placental villi. Eur J Clin Invest. 1995 Oct;25(10):796–798
  55. Merzouk H, Lamri MY, Meghelli-Bouchenak M, Korso N, Prost J, Belleville J. Serum lecithin: cholesterol acyltransferase activity and HDL2 and HDL3 composition in small for gestational age newborns. Acta Paediatr. 1997 May;86(5):528–532
  56. Spencer JA, Chang TC, Crook D, Proudler A, Felton CV, Robson SC, et al. Third trimester fetal growth and measures of carbohydrate and lipid metabolism in umbilical venous blood at term. Arch Dis Child Fetal Neonatal Ed. 1997 Jan;76(1):F21–F25
  57. Kaser S, Ebenbichler CF, Wolf HJ, Sandhofer A, Stanzl U, Ritsch A, et al. Lipoprotein profile and cholesteryl ester transfer protein in neonates. Metabolism. 2001 Jun;50(6):723–728

PII: S0143-4004(10)00262-6

doi: 10.1016/j.placenta.2010.07.002

Placenta
Volume 31, Issue 10 , Pages 893-901 , October 2010

Article Tools

* Image Usage & Resolution